Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04325542Not ApplicableCompleted

Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania

Role: lead

NCT03557021Not ApplicableUnknown

Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania

Role: lead

NCT01299948Phase 2Completed

Progression of HIV-Disease Under Low Dose Corticosteroids

Role: lead

All 3 trials loaded